Ascent Therapeutics
Cambridge · Founded 2006
About Ascent Therapeutics
Ascent Therapeutics offers Pepducins targeting GPCRs on the cell membrane, expanding the GPCR frontier.
Company Facts
- Founded: 2006
- Legal name: Ascent Therapeutics Inc
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $19.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2007)
- Website: ascentrx.com
- Phone: +1 617-715-1999
Social Profiles
Canonical: https://fsome.com/organization/ascent-therapeutics-8446179 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.